Jefferies Group Reiterates Buy Rating for Udg Healthcare PLC (UDG)
Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating reaffirmed by stock analysts at Jefferies Group in a report issued on Thursday. They currently have a GBX 400 ($6.71) price target on the stock. Jefferies Group’s price objective would indicate a potential upside of 13.64% from the stock’s previous close.
Udg Healthcare PLC (LON:UDG) traded up 1.90% during mid-day trading on Thursday, hitting GBX 358.70. 82,725 shares of the company’s stock traded hands. Udg Healthcare PLC has a 52 week low of GBX 293.30 and a 52 week high of GBX 380.10. The stock has a 50-day moving average of GBX 349.5 and a 200-day moving average of GBX 343.8. The company’s market cap is £865.9 million.
Other equities research analysts have also recently issued reports about the stock. Analysts at Davy Research reiterated an “outperform” rating on shares of Udg Healthcare PLC in a research note on Wednesday, May 14th. Separately, analysts at Goodbody Stockbrokers Ltd reiterated a “buy” rating on shares of Udg Healthcare PLC in a research note on Wednesday, May 14th. Finally, analysts at Investec raised their price target on shares of Udg Healthcare PLC from GBX 305 ($5.11) to GBX 360 ($6.04) in a research note on Wednesday, May 14th. They now have a “hold” rating on the stock. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of GBX 380 ($6.37).
UDG Healthcare plc is an international provider of services to healthcare manufacturers and pharmaceutical retailers, with operations in over 20 countries including the United States, the United Kingdom, Ireland, Germany, the Netherlands and Belgium.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.